{"DataElement":{"publicId":"2922106","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Tumor Stage","preferredDefinition":"Value to represent the extent of the deficiency of cellular immunity caused by the human immunodeficiency virus (HIV) as characterized by the occurrence and anatomic location of sites of disease.","longName":"AIDS_TUM_STG","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2921042","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Tumor Stage","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV).  It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes.  Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea.  Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma).  The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. -- 2004_An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"AIDS_TUM_STG","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2542204","version":"1","preferredName":"Acquired Immunodeficiency Syndrome","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","longName":"C2851","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"224D2D65-6714-4AEB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-15","modifiedBy":"ONEDATA","dateModified":"2006-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207384","version":"1","preferredName":"Neoplasm Stage","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3262:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-221E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363335-2E69-482D-E040-BB89AD434EEA","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2921050","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Tumor Stage","preferredDefinition":"An acquired defect in immune system function caused by human immunodeficiency virus (HIV).  AIDS is associated with increased susceptibility to certain cancers and to opportunistic infections, which are infections that occur rarely except in individuals with weak immune systems._An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"AIDS_TUM_STG","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"70","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0 - Confined to skin and/or lymph nodes and/or minimal oral disease","valueDescription":"0 - Confined to skin and/or lymph nodes and/or minimal oral disease","ValueMeaning":{"publicId":"2921055","version":"1","preferredName":"0 - Confined to skin and/or lymph nodes and/or minimal oral disease","longName":"2921055","preferredDefinition":"AIDS-related Kaposi sarcoma localized in the skin and/or the lymph nodes. This stage is associated with good risk of recovery.: Used to indicate that either or both of two items or options may be valid.: AIDS-related Kaposi sarcoma localized on the palate. The lesions are small and flat rather than raised. This stage is associated with good risk of recovery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T0 (Good Risk): Skin and/or Lymph Nodes","conceptCode":"C169109","definition":"AIDS-related Kaposi sarcoma localized in the skin and/or the lymph nodes. This stage is associated with good risk of recovery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"AIDS-Related Kaposi Sarcoma T0 (Good Risk): Minimal Oral Disease","conceptCode":"C169110","definition":"AIDS-related Kaposi sarcoma localized on the palate. The lesions are small and flat rather than raised. This stage is associated with good risk of recovery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C2AD-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB71325-48A4-B22C-E040-BB89AD430BB0","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"1 - Gastrointestinal KS","valueDescription":"1 - Gastrointestinal KS","ValueMeaning":{"publicId":"2921052","version":"1","preferredName":"1 - Gastrointestinal KS","longName":"2921052","preferredDefinition":"AIDS-related Kaposi sarcoma involving the esophagus, stomach, or intestines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Gastrointestinal Tract Involvement","conceptCode":"C134975","definition":"AIDS-related Kaposi sarcoma involving the esophagus, stomach, or intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C244-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB71325-48B8-B22C-E040-BB89AD430BB0","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"1 - Tumor associated edema or ulceration","valueDescription":"1 - Tumor associated edema or ulceration","ValueMeaning":{"publicId":"2921054","version":"1","preferredName":"1 - Tumor associated edema or ulceration","longName":"2921054","preferredDefinition":"AIDS-related Kaposi sarcoma with edema or ulceration due to the tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Edema or Ulceration","conceptCode":"C134973","definition":"AIDS-related Kaposi sarcoma with edema or ulceration due to the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C28A-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB71325-48CC-B22C-E040-BB89AD430BB0","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"1 - KS in other non-nodal viscera","valueDescription":"1 - KS in other non-nodal viscera","ValueMeaning":{"publicId":"2921051","version":"1","preferredName":"1 - KS in other non-nodal viscera","longName":"2921051","preferredDefinition":"AIDS-related Kaposi sarcoma involving organs other than the lungs or gastrointestinal tract. It includes liver, bladder, reproductive tract, heart, and endocrine organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Other Non-Nodal Viscera Involvement","conceptCode":"C134977","definition":"AIDS-related Kaposi sarcoma involving organs other than the lungs or gastrointestinal tract. It includes liver, bladder, reproductive tract, heart, and endocrine organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C221-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB71325-48E0-B22C-E040-BB89AD430BB0","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"1 - Extensive oral KS","valueDescription":"1 - Extensive oral KS","ValueMeaning":{"publicId":"2921053","version":"1","preferredName":"1 - Extensive oral KS","longName":"2921053","preferredDefinition":"AIDS-related Kaposi sarcoma with lesions that are nodular and/or lesions in roof of the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Extensive Oral Involvement","conceptCode":"C134974","definition":"AIDS-related Kaposi sarcoma with lesions that are nodular and/or lesions in roof of the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C267-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FB71325-48F4-B22C-E040-BB89AD430BB0","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-27","modifiedBy":"ONEDATA","dateModified":"2009-07-27","deletedIndicator":"No"},{"value":"1","valueDescription":"tumor associated edema, extensive oral disease, visceral disease","ValueMeaning":{"publicId":"5838505","version":"1","preferredName":"tumor associated edema, extensive oral disease, visceral disease","longName":"5838505","preferredDefinition":"AIDS-related Kaposi sarcoma with edema or ulceration due to the tumor.: AIDS-related Kaposi sarcoma with lesions that are nodular and/or lesions in roof of the mouth.: AIDS-related Kaposi sarcoma involving the esophagus, stomach, or intestines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Edema or Ulceration","conceptCode":"C134973","definition":"AIDS-related Kaposi sarcoma with edema or ulceration due to the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Extensive Oral Involvement","conceptCode":"C134974","definition":"AIDS-related Kaposi sarcoma with lesions that are nodular and/or lesions in roof of the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Gastrointestinal Tract Involvement","conceptCode":"C134975","definition":"AIDS-related Kaposi sarcoma involving the esophagus, stomach, or intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506E1A3E-DC8F-5DFD-E053-F662850A6637","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"506E1A3E-DCA8-5DFD-E053-F662850A6637","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"0","valueDescription":"limited skin and/or oral disease","ValueMeaning":{"publicId":"5838506","version":"1","preferredName":"limited skin and/or oral disease","longName":"5838506","preferredDefinition":"AIDS-related Kaposi sarcoma localized in the skin and/or the lymph nodes. This stage is associated with good risk of recovery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T0 (Good Risk): Skin and/or Lymph Nodes","conceptCode":"C169109","definition":"AIDS-related Kaposi sarcoma localized in the skin and/or the lymph nodes. This stage is associated with good risk of recovery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506E1A3E-DCB2-5DFD-E053-F662850A6637","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"506E1A3E-DCF6-5DFD-E053-F662850A6637","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"1 - Pulmonary KS","valueDescription":"1 - Pulmonary KS","ValueMeaning":{"publicId":"7185276","version":"1","preferredName":"1 - Pulmonary KS","longName":"7185276","preferredDefinition":"AIDS-related Kaposi sarcoma involving the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Pulmonary Involvement","conceptCode":"C134976","definition":"AIDS-related Kaposi sarcoma involving the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F7BD22A-A179-796B-E053-F662850AD2D7","latestVersionIndicator":"Yes","beginDate":"2020-02-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-26","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F7BD22A-A192-796B-E053-F662850AD2D7","beginDate":"2020-02-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-26","modifiedBy":"ONEDATA","dateModified":"2020-02-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2921049","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Neoplasm Stage","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C2851:C3262:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C1FC-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"ONEDATA","dateModified":"2009-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C20D-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"COOPERM","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"AIDS Tumor (T) Stage","type":"Preferred Question Text","description":"AIDS Tumor (T) Stage","url":null,"context":"CCR"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Tumor","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6F74B07E-A640-9C19-E040-BB89AD4373EA","latestVersionIndicator":"Yes","beginDate":"2009-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-24","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeDescription":"Curated for CCR Intramural trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}